European Journal of Dermatology

, Volume 25, Issue 1, pp 84–85 | Cite as

Subcutaneous sarcoidal granuloma underlying porokeratosis in a patient with sarcoid-lymphoma syndrome

Correspondence
  • 21 Downloads

Keywords

Sorafenib Sarcoidosis Vemurafenib Regorafenib Dabrafenib 

References

  1. 1.
    Karakantza M, Matutes E, MacLennan K, O’Conner NT, Srivastava PC, Catovsky D. Association between sarcoidosis and lymphoma revisited. J Clin Pathol 1996; 49: 208–12.CrossRefPubMedCentralPubMedGoogle Scholar
  2. 2.
    Kanitakis J. Porokeratoses: an update of clinical, aetiopathogenic and therapeutic features. Eur J Dermatol 2014; 24: 533–44.PubMedGoogle Scholar
  3. 3.
    Diluvio L, Campione E, Paterno EJ, et al. Acute onset disseminated superficial porokeratosis heralding diffuse large B-cell lymphoma. Eur J Dermatol 2008; 18: 349–50.PubMedGoogle Scholar
  4. 4.
    Pini M, Balice Y, Tavecchio S, Crippa D. Eruptive disseminated porokeratosis following bone marrow transplantation for acute lymphoblastic leukemia in a child. J Dermatol 2012; 39: 403–4.CrossRefPubMedGoogle Scholar
  5. 5.
    Ueda N, Satoh T, Yamamoto T, Yokozeki H. Nodular cystic fat necrosis in Heerfordt’s syndrome. J Eur Acad Dermatol Venereol 2007; 21: 708–9.PubMedGoogle Scholar
  6. 6.
    Tsunoda K, Onodera H, Akasaka T. Case of malignant melanoma associated with a sarcoid reaction. J Dermatol 2011; 39: 939–42.Google Scholar

Copyright information

© John Libbey Eurotext 2015

Authors and Affiliations

  1. 1.Department of DermatologyFukushima Medical UniversityFukushima960-1295Japan
  2. 2.Department of DermatologyTokyo Medical and Dental UniversityTokyoJapan

Personalised recommendations